CLINICIAN PROFILE

Dr Vamsi Krishna Yenamandra

Director, Genomics and Immunology · Professor of Dermatology

MBBS · MD-PhD (AIIMS) · Postdoc, UMC Groningen and Stanford

Physician-scientist. Developed AlphaSeq, now used in 96 countries. Pioneered NGS for large epidermolysis bullosa cohorts and work on topical gene therapy (Krystal / Vyjuvek). The campus laboratory runs an Illumina MiSeq i100.

What international families come for

• Rare and undiagnosed disease genomics
• Pharmacogenomics
• Precision immunology and biologics
• Epidermolysis bullosa and genodermatoses